|
PPP1CB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.662200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.004220E-01 |
| Normal-vs-Stage2 |
8.185800E-01 |
| Normal-vs-Stage3 |
8.577200E-01 |
| Normal-vs-Stage4 |
4.756800E-01 |
| Stage1-vs-Stage2 |
1.017200E-01 |
| Stage1-vs-Stage3 |
1.806030E-01 |
| Stage1-vs-Stage4 |
2.186200E-01 |
| Stage2-vs-Stage3 |
9.730200E-01 |
| Stage2-vs-Stage4 |
5.023600E-01 |
| Stage3-vs-Stage4 |
4.872800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.067800E-01 |
| Normal-vs-AfricanAmerican |
6.186000E-01 |
| Normal-vs-Asian |
7.031400E-01 |
| Caucasian-vs-AfricanAmerican |
5.063200E-01 |
| Caucasian-vs-Asian |
9.005000E-01 |
| AfricanAmerican-vs-Asian |
9.123800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.272400E-02 |
| Normal-vs-Female |
3.266800E-01 |
| Male-vs-Female |
3.414100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.351200E-01 |
| Normal-vs-Extreme_Weight |
1.971990E-02 |
| Normal-vs-Obese |
8.567800E-01 |
| Normal-vs-Extreme_Obese |
3.700800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.478400E-01 |
| Normal_Weight-vs-Obese |
1.494440E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.670000E-01 |
| Extreme_Weight-vs-Obese |
9.316500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.508600E-01 |
| Obese-vs-Extreme_Obese |
3.848400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.620200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.744200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.032000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.048400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.993400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.227900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.887500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.407780E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.431820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.863800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.495620E-01 |
| Normal-VS-Type2 PRCC |
1.082970E-01 |
| Normal-VS-KIRP CIMP |
1.394400E-02 |
| Normal-VS-Unclassified PRCC |
7.648800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.657800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.475200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.474300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.59089999995921E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.755900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.516200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.020010E-02 |
| Normal-vs-N1 |
1.333570E-01 |
| Normal-vs-N2 |
3.340000E-01 |
| N0-vs-N1 |
5.157000E-03 |
| N0-vs-N2 |
3.780400E-02 |
| N1-vs-N2 |
9.107000E-01 |
|
|
